Related Experiment Videos

Myocardial reperfusion: is it ever too late?

¹Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710.

Journal of the American College of Cardiology

|April 1, 1989

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Clinical, electrocardiographic, and biochemical data for immediate risk stratification in acute coronary syndromes.

Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc·2001

Prognostic importance of concomitant heparin with eptifibatide in acute coronary syndromes. PURSUIT Investigators. Platelet Glycoprotein IIb/IIIa in Unstable Angina: Receptor Suppression Using Integrilin Therapy.

The American journal of cardiology·2001

Therapeutic value of eptifibatide at community hospitals transferring patients to tertiary referral centers early after admission for acute coronary syndromes. PURSUIT Investigators.

Journal of the American College of Cardiology·2001

Treatment of reinfarction after thrombolytic therapy for acute myocardial infarction: an analysis of outcome and treatment choices in the global utilization of streptokinase and tissue plasminogen activator for occluded coronary arteries (gusto I) and assessment of the safety of a new thrombolytic (assent 2) studies.

Circulation·2001

Shifting the open-artery hypothesis downstream: the quest for optimal reperfusion.

Journal of the American College of Cardiology·2001

Patient characteristics associated with care by a cardiologist among adults hospitalized with severe congestive heart failure. SUPPORT Investigators. Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments.

Journal of the American College of Cardiology·2000

See all related articles